Maze Therapeutics Inc
(MAZE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 106,562 | -32,494 | -100,415 | 0 |
| Depreciation Amortization | 1,804 | 950 | 4,089 | 0 |
| Accounts payable and accrued liabilities | 144 | -243 | N/A | N/A |
| Other Working Capital | 2,678 | 249 | -6,316 | 0 |
| Other Operating Activity | 10,423 | 8,101 | 15,815 | 5,942 |
| Operating Cash Flow | $121,611 | $-23,437 | $-86,827 | $5,942 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -439 | -279 | -441 | 0 |
| Investing Cash Flow | $-439 | $-279 | $-441 | $0 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 24,475 | 24,216 | N/A | N/A |
| Common Stock Issued | 444 | 365 | N/A | N/A |
| Other Financing Activity | -184 | 0 | 16,385 | 0 |
| Financing Cash Flow | $24,735 | $24,581 | $16,385 | $0 |
| Beginning Cash Position | 30,246 | 30,246 | 101,129 | 0 |
| End Cash Position | 176,153 | 31,111 | 30,246 | 0 |
| Net Cash Flow | $145,907 | $865 | $-70,883 | $5,942 |
| Free Cash Flow | ||||
| Operating Cash Flow | 121,611 | -23,437 | -86,827 | 5,942 |
| Capital Expenditure | -439 | -279 | N/A | N/A |
| Free Cash Flow | 121,172 | -23,716 | -86,827 | 5,942 |